Renovaro Biosciences
$1.42
29
+$0.15+12.16% Tuesday 20:00
Statistics
Day High
1.42
Day Low
1.42
52W High
21
52W Low
1.12
Volume
810,969
Avg. Volume
218,513
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
15MayExpected
Expected EPS
N/A
Actual EPS
-0.16
Financials
-Profit Margin
Unprofitable0Revenue
-101.2MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow RENB. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.
Show more...
CEO
Mr. David H. Weinstein
Employees
25
Country
US
ISIN
US29350E1047
Listings
0 Comments
Share your thoughts
FAQ
What is Renovaro Biosciences stock price today?▼
The current price of RENB is $1.42 USD — it has increased by +12.16% in the past 24 hours. Watch Renovaro Biosciences stock price performance more closely on the chart.
What is Renovaro Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Renovaro Biosciences stocks are traded under the ticker RENB.
Is Renovaro Biosciences stock price growing?▼
RENB stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Renovaro Biosciences has showed a -69.79% decrease.
What were Renovaro Biosciences earnings last quarter?▼
RENB earnings for the last quarter are -0.16 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Renovaro Biosciences revenue for the last year?▼
Renovaro Biosciences revenue for the last year amounts to 0 USD.
What is Renovaro Biosciences net income for the last year?▼
RENB net income for the last year is -101.2M USD.
How many employees does Renovaro Biosciences have?▼
As of April 03, 2026, the company has 25 employees.
In which sector is Renovaro Biosciences located?▼
Renovaro Biosciences operates in the Health Care sector.
When did Renovaro Biosciences complete a stock split?▼
The last stock split for Renovaro Biosciences was on September 30, 2025 with a ratio of 1:10.
Where is Renovaro Biosciences headquartered?▼
Renovaro Biosciences is headquartered in Los Angeles, US.